Search

Author/Creator Climent, M.

2. Pembrolizumab vs investigator-choice chemotherapy for previously treated advanced urothelial cancer: Phase 3 KEYNOTE-045 study. (February 2017)

Authors:
Necchi, A.; Bellmunt, J.; De Wit, R.; Vaughn, D.; Fradet, Y.; Lee, J.L.; Fong, L.; Vogelzang, N.; Climent, M.; Petrylak, D.; Choueiri, T.; Gerritsen, W.; Gurney, H.; Quinn, D.; Culine, S.; Sternberg, C.; Mai, Y.; Puhlmann, M.; Perini, R.; Bajorin, D.
Journal:
European journal of cancer
Issue:
Volume 72(2017)Supplement 1
Page Start:
S2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer. Issue 1 (January 2016)

Authors:
Climent, M.; Hidalgo, N.; Vidal, Ó.; Puig, S.; Iglesias, M.; Cuatrecasas, M.; Ramón, J.M.; García-Albéniz, X.; Grande, L.; Pera, M.
Journal:
European journal of surgical oncology
Issue:
Volume 42:Issue 1(2016:Jan.)
Page Start:
132
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗